Available to sourceHuman Otc DrugGastrointestinal

Bioplasma

Tablet Soluble

By Hyland's Inc.

NDC: 54973-4086
Route: Oral
Therapeutic class: Blood Coagulation Factor , Calcium [CS], Calculi Dissolution Agent , Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative , Osmotic Laxative , Osmotic Laxative , Osmotic Laxative , Osmotic Laxative , Phosphate Binder , Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt , Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
Marketing category: UNAPPROVED HOMEOPATHIC

Package sizes

1 BOTTLE, PLASTIC in 1 CARTON (54973-4086-1) / 100 TABLET, SOLUBLE in 1 BOTTLE, PLASTICNDC 54973-4086-1Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.